| Item Type | Name |
|
Concept
|
B-Lymphocytes
|
|
Concept
|
T-Lymphocytes, Helper-Inducer
|
|
Concept
|
Lymphocyte Depletion
|
|
Concept
|
B-Lymphocyte Subsets
|
|
Concept
|
CD4-Positive T-Lymphocytes
|
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Epitopes, T-Lymphocyte
|
|
Concept
|
T-Lymphocytes, Cytotoxic
|
|
Concept
|
T-Lymphocytes, Regulatory
|
|
Concept
|
Lymphocyte Activation
|
|
Concept
|
Lymphocytes
|
|
Concept
|
T-Lymphocytes
|
|
Academic Article
|
Ring finger protein 43 as a new target for cancer immunotherapy.
|
|
Academic Article
|
Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
|
|
Academic Article
|
Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reactions in mice.
|
|
Academic Article
|
Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
|
|
Academic Article
|
Proliferation potential-related protein, an ideal esophageal cancer antigen for immunotherapy, identified using complementary DNA microarray analysis.
|
|
Academic Article
|
Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer.
|
|
Academic Article
|
ORAI1 genetic polymorphisms associated with the susceptibility of atopic dermatitis in Japanese and Taiwanese populations.
|
|
Academic Article
|
Association between genetic variation in the gene for death-associated protein-3 (DAP3) and adult asthma.
|
|
Academic Article
|
ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms.
|
|
Academic Article
|
Preapoptotic protease calpain-2 is frequently suppressed in adult T-cell leukemia.
|
|
Academic Article
|
Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice.
|
|
Academic Article
|
Cancer peptide vaccine therapy developed from oncoantigens identified through genome-wide expression profile analysis for bladder cancer.
|
|
Academic Article
|
Predictive biomarkers for the outcome of vaccination of five therapeutic epitope peptides for colorectal cancer.
|
|
Academic Article
|
Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.
|
|
Academic Article
|
Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer.
|
|
Academic Article
|
Cancer vaccines.
|
|
Academic Article
|
A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells.
|
|
Academic Article
|
Identification of an HLA-A2-restricted epitope peptide derived from hypoxia-inducible protein 2 (HIG2).
|
|
Academic Article
|
Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma.
|
|
Academic Article
|
Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray.
|
|
Academic Article
|
Identification of SPARC as a candidate target antigen for immunotherapy of various cancers.
|
|
Academic Article
|
A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population.
|
|
Academic Article
|
Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.
|
|
Academic Article
|
Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
|
|
Academic Article
|
FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling.
|
|
Academic Article
|
Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients.
|
|
Academic Article
|
HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL.
|
|
Academic Article
|
Identification of CDCA1-derived long peptides bearing both CD4+ and CD8+ T-cell epitopes: CDCA1-specific CD4+ T-cell immunity in cancer patients.
|
|
Academic Article
|
Retraction: Epstein-Barr virus-encoded latent membrane protein 1 activates ß-catenin signaling in B lymphocytes.
|
|
Academic Article
|
Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.
|
|
Academic Article
|
Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer.
|
|
Academic Article
|
Identification of HLA-A24-restricted novel T Cell epitope peptides derived from P-cadherin and kinesin family member 20A.
|
|
Academic Article
|
Characterization of T-cell Receptor Repertoire in Inflamed Tissues of Patients with Crohn's Disease Through Deep Sequencing.
|
|
Academic Article
|
Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation.
|
|
Academic Article
|
Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors.
|
|
Academic Article
|
Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy.
|
|
Academic Article
|
The forkhead box M1 transcription factor as a candidate of target for anti-cancer immunotherapy.
|
|
Academic Article
|
Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinoma.
|
|
Academic Article
|
Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study.
|
|
Academic Article
|
Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection.
|
|
Academic Article
|
Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer.
|
|
Academic Article
|
Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer.
|
|
Academic Article
|
Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer.
|
|
Academic Article
|
Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients.
|
|
Academic Article
|
Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia.
|
|
Academic Article
|
Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor-Engineered T Cells for Ovarian Cancer.
|
|
Academic Article
|
Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette-Guerin for patients with non-muscle invasive bladder cancer.
|
|
Academic Article
|
Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical Cancer.
|
|
Academic Article
|
Similarity and difference in tumor-infiltrating lymphocytes in original tumor tissues and those of in vitro expanded populations in head and neck cancer.
|
|
Academic Article
|
Dose escalation prophylactic donor lymphocyte infusion after T-cell depleted matched related donor allogeneic hematopoietic cell transplantation is feasible and results in higher donor chimerism, faster immune re-constitution, and prolonged progression-free survival.
|
|
Academic Article
|
Intranodal Administration of Neoantigen Peptide-loaded Dendritic Cell Vaccine Elicits Epitope-specific T Cell Responses and Clinical Effects in a Patient with Chemorefractory Ovarian Cancer with Malignant Ascites.
|
|
Academic Article
|
CD8 lymphocytes in tumors and nonsynonymous mutational load correlate with prognosis of bladder cancer patients treated with immune checkpoint inhibitors.
|
|
Academic Article
|
Diversity in immunogenomics: the value and the challenge.
|
|
Academic Article
|
Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma.
|
|
Academic Article
|
Neoantigens elicit T cell responses in breast cancer.
|
|
Academic Article
|
Established fibrous peritoneal metastasis in an immunocompetent mouse model similar to clinical immune microenvironment of gastric cancer.
|
|
Academic Article
|
Identification of cytotoxic T cells and their T cell receptor sequences targeting COVID-19 using MHC class I-binding peptides.
|
|
Academic Article
|
Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy.
|
|
Academic Article
|
SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck.
|
|
Academic Article
|
Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine.
|